1 / 2

In-Vitro Diagnostics Quality Control Market Analysis on Size, Cost Structure, Segment, Regional outlook and Forecast 202

The global in-vitro diagnostics quality control market was valued at US$ 854.0 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026.

kevinspot
Download Presentation

In-Vitro Diagnostics Quality Control Market Analysis on Size, Cost Structure, Segment, Regional outlook and Forecast 202

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. In-Vitro Diagnostics Quality Control MarketOverview, Trends and Forecast to 2026 JustPublished • The latest market report published by Credence Research, Inc. “In-Vitro Diagnostics Quality Control Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global in-vitro diagnostics qualitycontrolmarketwasvaluedatUS$854.0Mnin2017andexpectedtogrowatcompoundannual growthrate(CAGR)of3.9%duringtheforecastperiodfrom2018to2026. • MarketInsights • The global in-vitro diagnostics quality control market is projected to grow at a steady rate during the forecast period. The major reason for the growth of the market includes growing applications of in-vitro diagnostics and point-of-care diagnostics for various diseases such as chronic diseases, infectious diseases and oncology testing. Quick testing and accurate results have positioned in-vitro diagnostics testing in modern healthcare. In-vitro diagnostics fall under medical devices category and hence Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA) and other regulatory bodies have implemented stringent regulatory process for maintaining the standard quality and safety of the testing systems. This factor is the major growth driver for in-vitro diagnostics quality control market.Increasingnumberofclinicaland diagnosticslaboratoriesworldwide isalso influencingthemarket growth. In terms of application, the market is led by clinical chemistry owing to growing application in chronic diseases, most prominently in cancer treatment and cardiovascular treatment. Immunochemistry also held a prominent share in the market due to urgent requirement for novel drug discovery and increasing physician awareness regarding disease etiology will propel market penetration for immunochemistrysegment. • Don’t Miss the Sample @https://www.credenceresearch.com/sample-request/59637 • In terms of geography, North America accounted for the maximum share of in-vitro diagnostics quality controlmarket.NorthAmerica is adomiciletomajordiagnosticlaboratoriesand serviceproviders.The • FDAand HealthCanadahavedesignedstringentqualitycontrolpoliciesforIVDtomaintainthesafety • and accuracy of the tests. Growing government funded research and development to cater burden of diseaseswillfurtherdrivethemarketintheregion.AsiaPacificemergedasthefastestgrowingregion owing to growing usage of IVD testing and rising applications in the region. Surge in contract manufacturing and research for drug discovery and clinical chemistry in the region will drive market. Growing healthcare infrastructure and high unmet needs is attributable to growth of the market. Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine supports the growth of IVD and assures accuracy and safety of the testingsystems. • The key players currently engaged in In-vitro diagnostics quality control market include Siemens Healthineers, Thermo Fisher Scientific, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Seracare Life Sciences, Inc., Sysmex Corporation, Helena Laboratories, Sun Diagnostics, LLC amongothers. • Key MarketMovements: • Growingburdenofchronicdisorders,cancerandinfectiousdiseasesgloballydrivingthedemand for in-vitro diagnostics qualitycontrol • StringentregulatorypoliciesformaintainingtheaccuracyandsafetyoftheIVDtests

  2. GrowingdiagnosticlaboratoriesacrosstheworldwilldrivethedemandforIVDqualitycontrolGrowingdiagnosticlaboratoriesacrosstheworldwilldrivethedemandforIVDqualitycontrol • For More Inquiry: https://www.credenceresearch.com/inquiry-before-buying/59637 AboutUs • Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance withmakingenduringenhancementstotheirexecutionand understandtheirmostimperativeobjectives. Overalmostacentury,we'vemanufacturedafirmextraordinarilypreparedtothistask. • Registered OfficeAddress: • Credence Research Limited Kemp House 160 CityRoad London • EC1V2NX • UnitedKingdom • Credence Research Inc. 105 N 1st ST #429 SANJOSE • CA95103 • UnitedStates • Toll Free (US/CANADA):+1-800-361-8290 • sales@credenceresearch.com

More Related